Evidence map›Paper›PMID 34727329›Full record

Observational studyInternational journal of hematology2022

Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.

Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka and 14 more

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in International journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Yoshinori HashimotoDepartment of Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Tomoki ItoFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Akihiko GotohDepartment of Hematology, Tokyo Medical University, Tokyo, Japan.
Mika NakamaeHematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Fumihiko KimuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
Michiaki KoikeDepartment of Hematology, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
Keita KiritoDepartment of Hematology and Oncology, University of Yamanashi, Yamanashi, Japan.
Hideho WadaDepartment of Hematology, Kawasaki Medical School, Okayama, Japan.
Kensuke UsukiDepartment of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
Takayuki TanakaDepartment of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
Takehiko MoriDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Satoshi WakitaDivision of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Toshiki I SaitoClinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Akiko KadaClinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Akiko M SaitoClinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Kazuya ShimodaDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Yuka SugimotoDepartment of Community Hematology, Mie University, Mie, Japan.
Toshiro KurokawaDepartment of Hematology, Toyama Red Cross Hospital, Toyama, Japan.
Akihiro TomitaDepartment of Hematology, Fujita Health University School of Medicine, Aichi, Japan.
Yoko EdahiroDepartment of Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Koichi AkashiDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Itaru MatsumuraDivision of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan.
Katsuto TakenakaDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.
Norio KomatsuDepartment of Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. komatsun@juntendo.ac.jp.ORCID http://orcid.org/0000-0003-1880-9126

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a large-scale, nationwide retrospective study of Japanese patients who were diagnosed with essential thrombocythemia based on the diagnostic criteria in the World Health Organization classification. We investigated clinical characteristics, survival rates, and the incidence of thrombohemorrhagic events as well as risk factors for these events. A total of 1152 patients were analyzed in the present study. Median age at diagnosis was 65 years, the median platelet count was 832 × 10

Indexed as

AdultAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsSurvival AnalysisThrombocythemia, EssentialYoung AdultEssential thrombocythemiaNationwide surveyPrognostic factorsRisk factors

Identifiers

PMID34727329

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.